Discover trends, market shifts, and competitive outlooks for the desmoid tumors industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Desmoid Tumors Market From 2025 To 2029?

There has been a robust expansion in the desmoid tumors market size in the past few years. It is predicted to increase from a worth of $2.97 billion in 2024 to a value of $3.18 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.3%. Developments in medical imaging, genetic studies, awareness and education, advanced surgical procedures, and patient advocacy underpin the growth in the historic period.

In the coming years, solid expansion is projected for the desmoid tumors market. By 2029, it’s estimated to reach $4.13 billion, boasting a compound annual growth rate (CAGR) of 6.8%. This growth during the forecast period can be linked to factors such as personalized medicine, targeted therapies, broadened global collaborations, novel therapy regulatory approvals, and patient-focused approaches. Main trends anticipated within this period encompass progress in treatment methods, precision medicine and biomarker identification, clinical trials and research activities, multidisciplinary treatment groups, as well as patient advocacy and support.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13228&type=smp

Which Factors and External Forces Are Driving Demand in the Desmoid Tumors Market?

The escalating incidence of cancer is anticipated to drive the expansion of the desmoid tumor market. Cancer is characterized by abnormal cell growth and spread which can infiltrate and damage adjacent tissues and organs. The global rise in cancer incidence has amplified the need for advanced and effective chemotherapy drugs, thereby positively impacting the desmoid tumor market. For instance, the National Cancer Institute reported in May 2024 that it is projected that there will be 2,001,140 new cancer cases and 611,720 deaths as a result of the disease in the U.S. in 2024 alone. Additionally, in 2022, nearly 20 million new cancer cases and 9.7 million deaths due to cancer were recorded globally. By 2040, the annual number of new cancer diagnoses is expected to climb to 29.9 million, and cancer-related deaths could reach 15.3 million. These rising cancer rates are contributing to the growth of the desmoid tumor market.

Desmoid Tumors Market Driver: Government Investments in Research and Development to Bolster Desmoid Tumor Market Growth

Which Segments in the Desmoid Tumors Offer the Most Growth?

The desmoid tumors market covered in this report is segmented –

1) By Treatment: Surgery, Radiation Therapy, Anti-Inflammatory Medication, Hormone Therapy, Chemotherapy, Novel Molecular-Targeted Therapy, Other Treatments

2) By Diagnosis: Biopsy, Electron Microscopic Examination, Immunohistochemical Analysis, Other Diagnosis

3) By End-User: Hospitals And Clinics, Specialty Centers, Other End-Users

Subsegments:

1) By Surgery: Wide Excision, Minimally Invasive Surgery

2) By Radiation Therapy: External Beam Radiation Therapy, Stereotactic Body Radiation Therapy

3) By Anti-Inflammatory Medication: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids

4) By Hormone Therapy: Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors

5) By Chemotherapy: Traditional Chemotherapy Agents, Combination Chemotherapy

6) By Novel Molecular-Targeted Therapy: Tyrosine Kinase Inhibitors, Other Targeted Therapies

7) By Other Treatments: Watchful Waiting, Physical Therapy, Pain Management Strategies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13228&type=smp

What Are the Fastest-Growing Geographies in the Desmoid Tumors Market?

North America was the largest region in the desmoid tumors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the desmoid tumors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Cutting-Edge Market Trends Are Expected to Drive theDesmoid Tumors Market’s Growth?

Leading corporations in the desmoid tumors market are focusing on the creation of novel treatments such as nirogacestat to better cater to the requirements of their clientele. Nirogacestat is an orally administered, small-molecule gamma-secretase inhibitor. For example, in February 2023, SpringWorks Therapeutics Inc., a clinical-stage biopharmaceutical company based in the US, reported that their New Drug Application (NDA) for nirogacestat for the treatment of adults with desmoid tumors had been accepted and given a priority review by the U.S. Food and Drug Administration (FDA). Nirogacestat is assumed to function by inhibiting the production of notch proteins that may result in tumor cell demise. Desmoid tumors are notorious for generating excessive amounts of notch protein, which is believed to fuel their proliferation. Nirogacestat offers patients a fresh treatment alternative that could potentially enhance their medical results.

View the full report here:

https://www.thebusinessresearchcompany.com/report/desmoid-tumors-global-market-report

What Are the Key Elements That Define the Desmoid Tumors Market?

Desmoid tumors refer to rare non-cancerous (benign) tumors that arise from connective tissue cells, usually in the fascia, which is the tissue that surrounds muscles, nerves, and blood vessels. These tumors are locally aggressive, which means they can grow and invade nearby structures but do not spread to distant parts of the body like traditional cancer.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13228

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model